摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-phenoxypyridin-4-yl)methanol | 112946-05-1

中文名称
——
中文别名
——
英文名称
(3-phenoxypyridin-4-yl)methanol
英文别名
3-Phenoxy-4-pyridinemethanol
(3-phenoxypyridin-4-yl)methanol化学式
CAS
112946-05-1
化学式
C12H11NO2
mdl
——
分子量
201.225
InChiKey
PDXLLVWFBFRVTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    42.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (3-phenoxy-4-pyridinyl)methyl acetatesodium methylate 作用下, 以 甲醇 为溶剂, 反应 24.0h, 以51%的产率得到(3-phenoxypyridin-4-yl)methanol
    参考文献:
    名称:
    3-Phenoxypyridine 1-oxides as anticonvulsant agents
    摘要:
    The anticonvulsant activity of a series of 3-phenoxypyridine 1-oxides is described. An investigation carried out to optimize the activity/side effect ratio provided 4-methyl-3-phenoxypyridine 1-oxide, 3, as the derivative of choice. Overall, 3 has a pharmacological profile that is very similar to phenytoin. It exhibited significant anticonvulsant activity at doses that did not produce ataxia or sedation but caused increased spontaneous behavioral activity not seen with most anticonvulsants. The short duration of pharmacological effect of 3 was attributed to metabolic hydroxylation at the C-4 pyridine methyl group; however, structural modifications designed to inhibit this metabolic pathway were unsuccessful.
    DOI:
    10.1021/jm00399a027
点击查看最新优质反应信息

文献信息

  • [EN] AMINOPYRAZINE COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF<br/>[FR] COMPOSÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE HPK1 ET LEUR UTILISATION
    申请人:BEIGENE LTD
    公开号:WO2021032148A1
    公开(公告)日:2021-02-25
    Disclosed herein is an aminopyrazine compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.
    本文揭示了一种式(I)的氨基吡嗪化合物,或其立体异构体,或其药学上可接受的盐,以及包含它们的药物组合物。还公开了利用本文所披露的化合物治疗HPK1相关疾病或疾病的方法。
查看更多